Some recent developments associated with corporate governance and shareholder activism have shown that shareholder empowerment is vital nowadays. Hence, there is a dire need for minority shareholders to be more active and responsive in their dealings with corporations. Active shareholder engagement safeguards the interests and the rights of the minority shareholders from the effect of agency relationships and from the consequences of the unique atmosphere of shareholder activism in Malaysia. A conceptual discussion on shareholder activism has led to a conclusion that shareholder activism in developed countries cannot explain the state of activism in emerging economies, like Malaysia.
The topic of shareholder activism has become an important issue for discussion in the corporate world, and debate continues to exist with regard to this matter. In the corporate world, the minority shareholders are the least protected corporate participants, due to their minimal voice in corporate decision-making. This paper is not empirically based but merely conceptual. Therefore, it is aimed at presenting the preliminary work for a study. The concepts of corporate governance, ownership structure and control, shareholder-companies relationship and majority-minority shareholders relationship are discussed, in order to gain an understanding of the concept and some practical perspectives of shareholder activism. From the discussion, several missing parameters of shareholder activism were derived. These missing parameters are considered red flags; there is a dire need to conduct further research for a better understanding of this important topic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.